Pharmaceuticals
Bayer, Novartis, Reckitt Benckiser, P&G in fray for Merck & Co's consumer healthcare unit
20 Feb 2014
Bayer, Novartis, Reckitt Benckiser, and Procter & Gamble are among the companies that are exploring a deal to buy Merck &Co's consumer healthcare unit
Actavis to acquire Forest Laboratories for $25 billion
19 Feb 2014
The deal, the largest in the pharmaceutical sector so far this year, will create a specialty pharmaceuticals giant
FDA pushes for warnings on generic drugs
18 Feb 2014
Actavis in talks to buy Forest Laboratories for around $25 bn
18 Feb 2014
Actavis, the world's third-largest generics prescription drug manufacturer, hopes to use the Forest acquisition to deal with the tying up of hospitals, insurers and doctors to negotiate directly to buy prescription drugs at cheaper rates from manufacturers
.webp)
.webp)
